Síndrome inflamatorio multisistémico en paciente con leucemia
El síndrome inflamatorio multisistémico post COVID-19 (SIM-C) es una entidad inflamatoria post infecciosa asociada al Coronavirus SARS CoV-2, actualmente infrecuente y superpuesta con otras entidades.
Agustina Zwirner +7 more
doaj
[COVID-19, Guillain-Barré syndrome, and the vaccine. A dangerous combination]. [PDF]
Aomar-Millán IF +3 more
europepmc +1 more source
[Risk of thrombosis recurrence among patients with COVID-19- and surgery-associated venous thromboembolism]. [PDF]
Alonso-Beato R +7 more
europepmc +1 more source
[Neurocovid-19: effects of COVID-19 on the brainNeurocovid-19: efeitos da COVID-19 no cérebro]. [PDF]
Matar-Khalil S.
europepmc +1 more source
[Fatal outcome of COVID-19 disease in a 5-month infant with comorbidities]. [PDF]
Climent FJ +5 more
europepmc +1 more source
[Baricitinib in the treatment of SARS-CoV-2 infection]. [PDF]
Gutiérrez-Lorenzo M +1 more
europepmc +1 more source
Seguimiento de los pacientes con secuelas no respiratorias de la COVID-19. [PDF]
Hernando JEC.
europepmc +1 more source
[COVID-19 associated Kawasaki-like multisystem inflammatory syndrome in an adult]. [PDF]
Elouardi Y +5 more
europepmc +1 more source
[Effects of the COVID-19 pandemic on a cohort of patients with vein occlusion]. [PDF]
García Palacios JD +3 more
europepmc +1 more source
Immunology in COVID-19; more than diagnosis of infection or the basis of vaccination. [PDF]
Egri N, Juan M.
europepmc +1 more source

